Efficacy, Safety, and Tolerability Study of ACT-129968 in Patients With Seasonal Allergic Rhinitis

NCT01484119 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

630

Enrollment

INDUSTRY

Sponsor class

Conditions

Seasonal Allergic Rhinitis

Interventions

DRUG: ACT-129968
DRUG: Placebo
DRUG: Cetirizine

Sponsor

Idorsia Pharmaceuticals Ltd.